RESULTS: The median age at
time of local recurrence was 50 years. All patients had Kadish C disease at initial diagnosis. Six of 8 patients were found to have Hyams grade 3 disease; the remaining 2 patients had grade 2 disease. The median treatment volume was 8.4 cm(3) (mean, 18.9 cm(3); range, 1.4-76.3 cm(3)), and the median dose to the tumor margin was 15 Gy (mean, 14.4 +/- 2.2 Gy; range, 10-18 Gy). Of the Sonidegib 16 treatments, 13 had adequate follow-up to assess treatment response, with 92% achieving local control over a median follow-up of 42 months from the time of SRS. Five lesions decreased in size, 7 lesions stabilized, and only 1 lesion had in-field progression. There were no documented complications secondary to SRS.
CONCLUSION: SRS appears to be a reasonable and safe option for treatment of intracranial recurrence of ENB.”
“Despite evidence from case series, the comorbidity of Repotrectinib ic50 eating disorders with psychosis is less investigated than their comorbidity with anxiety and mood disorders, We investigated the occurrence of symptoms of psychosis in 112 female patients diagnosed with DSM-IV eating disorders (anorexia nervosa=61, bulimia nervosa = 51) and
631 high school girls in the same health district as the patients: the items of the SCL-90R symptom dimensions “”paranoid ideation”" and “”psychoticism”" were specifically examined. No case of comorbid schizophrenia was observed among patients. Compared with controls, the patients with anorexia nervosa were more likely to endorse the item “”Never feeling close to another person”"; the patients with bulimia nervosa were more likely to endorse the item “”Feeling others are to blame for your troubles”". Both groups of patients were more likely than controls
to endorse the item “”Idea that something is wrong with your mind”". The students who were identified by the EAT and the BITE as being “”at risk”" for eating disorders were more likely to assign their body a causative role in their problems. Symptoms of psychosis can PDK3 be observed in patients with eating disorders, but these could be better explained within the psychopathology of the disorders rather than by assuming a link with schizophrenia. (C) 2009 Elsevier Ireland Ltd. All rights reserved.”
“BACKGROUND: Onyx HD-500 is a liquid embolic used to treat intracranial aneurysms.
OBJECTIVE: To determine the incidence of parent vessel stenosis and the management strategy for these patients.
METHODS: Medical records of patients treated with Onyx HD-500 between 2008 and 2011 were retrospectively reviewed. Clinical and radiographic evaluations were assessed. Quantitative magnetic resonance angiography and NOVA (VasSol, Chicago, Illinois) images were reviewed for patients in whom these examinations were acquired.
RESULTS: Seventeen patients underwent treatment of unruptured internal carotid artery aneurysms. Three patients (17.6%) developed visual symptoms after the procedure: 2 permanent and 1 transient.